In the tumor tissues, mRNA expression of CSPG4 and CHST15 declined following treatment with exogenous ARSB (p < 0.001, two-sample t-test, two-tailed, unequal variance, n = 6) (Fig. 2D). The gene discussed is CSPG4; the disease is neoplasm.